Literature DB >> 20837779

Hepcidin induction by transgenic overexpression of Hfe does not require the Hfe cytoplasmic tail, but does require hemojuvelin.

Paul J Schmidt1, Nancy C Andrews, Mark D Fleming.   

Abstract

Mutations in HFE cause the most common form of hereditary hemochromatosis (HH). We previously showed that liver-specific, transgenic overexpression of murine Hfe stimulates production of the iron regulatory hormone hepcidin. Here, we developed several additional transgenic mouse strains to further interrogate the structural basis of HFE function in the pathophysiology of HH. We hypothesized that the small, cytoplasmic domain of HFE might be necessary for HFE-mediated induction of hepcidin. We demonstrate that, like the full-length protein, overexpression of Hfe proteins lacking the cytoplasmic domain leads to hepcidin induction, iron deficiency and a hypochromic, microcytic anemia. However, high-level expression of a liver-specific Hfe transgene carrying the mouse equivalent of the common HFE C282Y human disease-causing mutation (murine C294Y) did not cause iron deficiency. Furthermore, hepcidin induction by transgenes encoding both WT Hfe and Hfe lacking its cytoplasmic domain is greatly attenuated in the absence of hemojuvelin (Hjv). Our observations indicate that the extracellular and transmembrane domains of Hfe are sufficient, and Hjv is essential, for Hfe-mediated induction of hepcidin expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20837779      PMCID: PMC3031413          DOI: 10.1182/blood-2010-04-277954

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  52 in total

1.  Interactions of the ectodomain of HFE with the transferrin receptor are critical for iron homeostasis in cells.

Authors:  C N Roy; E J Carlson; E L Anderson; A Basava; S M Starnes; J N Feder; C A Enns
Journal:  FEBS Lett       Date:  2000-11-10       Impact factor: 4.124

2.  Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation.

Authors:  Cinzia Garuti; Yinghua Tian; Giuliana Montosi; Manuela Sabelli; Elena Corradini; Rolf Graf; Paolo Ventura; Alberto Vegetti; Pierre-Alain Clavien; Antonello Pietrangelo
Journal:  Gastroenterology       Date:  2010-03-22       Impact factor: 22.682

3.  Mutational analysis of the transferrin receptor reveals overlapping HFE and transferrin binding sites.

Authors:  A P West; A M Giannetti; A B Herr; M J Bennett; J S Nangiana; J R Pierce; L P Weiner; P M Snow; P J Bjorkman
Journal:  J Mol Biol       Date:  2001-10-19       Impact factor: 5.469

4.  Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis.

Authors:  Martina Muckenthaler; Cindy N Roy; Angel O Custodio; Belén Miñana; Jos deGraaf; Lynne K Montross; Nancy C Andrews; Matthias W Hentze
Journal:  Nat Genet       Date:  2003-05       Impact factor: 38.330

5.  Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis.

Authors:  Gaël Nicolas; Lydie Viatte; Dan-Qing Lou; Myriam Bennoun; Carole Beaumont; Axel Kahn; Nancy C Andrews; Sophie Vaulont
Journal:  Nat Genet       Date:  2003-05       Impact factor: 38.330

6.  Severe iron deficiency anemia in transgenic mice expressing liver hepcidin.

Authors:  Gaël Nicolas; Myriam Bennoun; Arlette Porteu; Sandrine Mativet; Carole Beaumont; Bernard Grandchamp; Mario Sirito; Michèle Sawadogo; Axel Kahn; Sophie Vaulont
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

7.  Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.

Authors:  Kim R Bridle; David M Frazer; Sarah J Wilkins; Jeanette L Dixon; David M Purdie; Darrell H G Crawford; V Nathan Subramaniam; Lawrie W Powell; Gregory J Anderson; Grant A Ramm
Journal:  Lancet       Date:  2003-02-22       Impact factor: 79.321

8.  Expression of the hereditary hemochromatosis protein HFE increases ferritin levels by inhibiting iron export in HT29 cells.

Authors:  Paige S Davies; Caroline A Enns
Journal:  J Biol Chem       Date:  2004-03-25       Impact factor: 5.157

9.  Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis.

Authors:  George Papanikolaou; Mark E Samuels; Erwin H Ludwig; Marcia L E MacDonald; Patrick L Franchini; Marie-Pierre Dubé; Lisa Andres; Julie MacFarlane; Nikos Sakellaropoulos; Marianna Politou; Elizabeta Nemeth; Jay Thompson; Jenni K Risler; Catherine Zaborowska; Ryan Babakaiff; Christopher C Radomski; Terry D Pape; Owen Davidas; John Christakis; Pierre Brissot; Gillian Lockitch; Tomas Ganz; Michael R Hayden; Y Paul Goldberg
Journal:  Nat Genet       Date:  2003-11-30       Impact factor: 38.330

10.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis.

Authors:  Antonella Roetto; George Papanikolaou; Marianna Politou; Federica Alberti; Domenico Girelli; John Christakis; Dimitris Loukopoulos; Clara Camaschella
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

View more
  16 in total

Review 1.  Unraveling mechanisms regulating systemic iron homeostasis.

Authors:  Karin E Finberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

Review 2.  Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.

Authors:  Chia Chi Sun; Valentina Vaja; Jodie L Babitt; Herbert Y Lin
Journal:  Am J Hematol       Date:  2012-01-31       Impact factor: 10.047

Review 3.  Murine mutants in the study of systemic iron metabolism and its disorders: an update on recent advances.

Authors:  Thomas B Bartnikas; Mark D Fleming; Paul J Schmidt
Journal:  Biochim Biophys Acta       Date:  2012-01-28

4.  [Side effects of tumor pharmacotherapy. What internists should know].

Authors:  E Wollmer; A Neubauer
Journal:  Internist (Berl)       Date:  2011-12       Impact factor: 0.743

5.  Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice.

Authors:  Karin E Finberg; Rebecca L Whittlesey; Nancy C Andrews
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

6.  HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression.

Authors:  Xing-Gang Wu; Yang Wang; Qian Wu; Wai-Hang Cheng; Wenjing Liu; Yueshui Zhao; Claire Mayeur; Paul J Schmidt; Paul B Yu; Fudi Wang; Yin Xia
Journal:  Blood       Date:  2014-06-05       Impact factor: 22.113

7.  Transgenic HFE-dependent induction of hepcidin in mice does not require transferrin receptor-2.

Authors:  Paul J Schmidt; Mark D Fleming
Journal:  Am J Hematol       Date:  2012-03-28       Impact factor: 10.047

8.  Hemojuvelin is essential for transferrin-dependent and transferrin-independent hepcidin expression in mice.

Authors:  Thomas B Bartnikas; Mark D Fleming
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

9.  An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.

Authors:  Paul J Schmidt; Iva Toudjarska; Anoop K Sendamarai; Tim Racie; Stuart Milstein; Brian R Bettencourt; Julia Hettinger; David Bumcrot; Mark D Fleming
Journal:  Blood       Date:  2012-12-06       Impact factor: 22.113

10.  The IRP1-HIF-2α axis coordinates iron and oxygen sensing with erythropoiesis and iron absorption.

Authors:  Sheila A Anderson; Christopher P Nizzi; Yuan-I Chang; Kathryn M Deck; Paul J Schmidt; Bruno Galy; Alisa Damnernsawad; Aimee T Broman; Christina Kendziorski; Matthias W Hentze; Mark D Fleming; Jing Zhang; Richard S Eisenstein
Journal:  Cell Metab       Date:  2013-02-05       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.